A tumor-promoting effect of neurofibromin loss in nonepithelial melanoma has been suggested by a greater than expected frequency of uveal melanoma in patients with neurofibromatosis type 1 (heterozygous germline NF1 mutation carriers; ref. 20). The gene discussed is NF1; the disease is neurofibromatosis type 1.